Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable.


Journal

Circulation
ISSN: 1524-4539
Titre abrégé: Circulation
Pays: United States
ID NLM: 0147763

Informations de publication

Date de publication:
19 03 2019
Historique:
pubmed: 1 2 2019
medline: 31 12 2019
entrez: 1 2 2019
Statut: ppublish

Résumé

Efforts to improve prescription of oral anticoagulation (OAC) drugs in patients with atrial fibrillation have had limited success in improving guideline adherence. We evaluated adherence to the American College of Cardiology/American Heart Association performance measures for OAC in eligible patients with a CHA The median (25th, 75th percentile) age was 73 years (65, 81 years); 51% were female; and the median (25th, 75th percentile) CHA Among hospitals participating in the GWTG-AFIB quality improvement program, OAC prescription at discharge in eligible guideline-indicated patients increased significantly and improved consistently over time. These data confirm that high-level adherence to guideline-recommended stroke prevention is achievable.

Sections du résumé

BACKGROUND
Efforts to improve prescription of oral anticoagulation (OAC) drugs in patients with atrial fibrillation have had limited success in improving guideline adherence.
METHODS
We evaluated adherence to the American College of Cardiology/American Heart Association performance measures for OAC in eligible patients with a CHA
RESULTS
The median (25th, 75th percentile) age was 73 years (65, 81 years); 51% were female; and the median (25th, 75th percentile) CHA
CONCLUSIONS
Among hospitals participating in the GWTG-AFIB quality improvement program, OAC prescription at discharge in eligible guideline-indicated patients increased significantly and improved consistently over time. These data confirm that high-level adherence to guideline-recommended stroke prevention is achievable.

Identifiants

pubmed: 30700141
doi: 10.1161/CIRCULATIONAHA.118.035909
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1497-1506

Auteurs

Jonathan P Piccini (JP)

Duke Clinical Research Institute and Duke University Medical Center, Durham, NC (J.P.P., H.X., M.C., R.A.M.).

Haolin Xu (H)

Duke Clinical Research Institute and Duke University Medical Center, Durham, NC (J.P.P., H.X., M.C., R.A.M.).

Margueritte Cox (M)

Duke Clinical Research Institute and Duke University Medical Center, Durham, NC (J.P.P., H.X., M.C., R.A.M.).

Roland A Matsouaka (RA)

Duke Clinical Research Institute and Duke University Medical Center, Durham, NC (J.P.P., H.X., M.C., R.A.M.).

Gregg C Fonarow (GC)

Ronald Reagan-UCLA Medical Center, University of California, Los Angeles (G.C.F.).

Javed Butler (J)

Stony Brook University School of Medicine, NY (J.B.).

Anne B Curtis (AB)

University at Buffalo, NY (A.B.C.).

Nihar Desai (N)

Yale University, New Haven, CT (N.D.).

Margaret Fang (M)

University of California, San Francisco (M.F.).

Pamela J McCabe (PJ)

Mayo Clinic, Rochester, MN (P.J.M.).

Robert L Page Ii (RL)

University of Colorado Skaggs School of Pharmacy, Aurora (R.L.P.).

Mintu Turakhia (M)

VA Palo Alto Health Care System and Stanford University School of Medicine, CA (M.T.).

Andrea M Russo (AM)

Cooper University Hospital, Camden, NJ (A.M.R.).

Bradley P Knight (BP)

Feinberg School of Medicine, Northwestern University, Chicago, IL (B.P.K.).

Mandeep Sidhu (M)

Albany Medical Center, NY (M.S.).

Jodie L Hurwitz (JL)

North Texas Heart Center, Dallas (J.L.H.).

Kenneth A Ellenbogen (KA)

Virginia Commonwealth University, Richmond (K.A.E.).

William R Lewis (WR)

MetroHealth System Campus, Case Western Reserve University, Cleveland, OH (W.R.L.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH